TCI Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-163
Closed -$4K 2265
2022
Q1
$4K Sell
163
-153
-48% -$3.47K ﹤0.01% 1658
2021
Q4
$9K Buy
316
+185
+141% +$5.11K ﹤0.01% 1224
2021
Q3
$3K Buy
131
+28
+27% +$749 ﹤0.01% 1895
2021
Q2
$3K Buy
+103
New +$2.52K ﹤0.01% 1696
2020
Q2
Sell
-52
Closed -$1K 1455
2020
Q1
$1K Hold
52
﹤0.01% 1175
2019
Q4
$1K Hold
52
﹤0.01% 1276
2019
Q3
$1K Hold
52
﹤0.01% 1219
2019
Q2
$1K Hold
52
﹤0.01% 1135
2019
Q1
$1K Hold
52
﹤0.01% 1142
2018
Q4
$1K Sell
52
-47
-47% -$973 ﹤0.01% 1135
2018
Q3
$2K Sell
99
-95
-49% -$2.11K ﹤0.01% 994
2018
Q2
$4K Buy
194
+142
+273% +$2.9K ﹤0.01% 822
2018
Q1
$1K Hold
52
﹤0.01% 1080
2017
Q4
$1K Hold
52
﹤0.01% 1130
2017
Q3
$1K Hold
52
﹤0.01% 1057
2017
Q2
$1K Hold
52
﹤0.01% 1086
2017
Q1
$1K Hold
52
﹤0.01% 1034
2016
Q4
$1K Hold
52
﹤0.01% 1115
2016
Q3
$1K Hold
52
﹤0.01% 1074
2016
Q2
$1K Hold
52
﹤0.01% 1019
2016
Q1
$1K Buy
+52
New +$574 ﹤0.01% 1040

Other funds holding ANGO

TCI Wealth Advisors's ANGO Position: Q2 2022 in Review

TCI Wealth Advisors sold out of AngioDynamics (ANGO) in Q2 2022, closing a stake of 163 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in ANGO in Q1 2016 and held it in 21 quarters. The position peaked at $9K in Q4 2021. 134 funds tracked by Wall St. Rank hold ANGO as of Q2 2022.

  • TCI Wealth Advisors reported no remaining AngioDynamics position as of Q2 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 163 AngioDynamics shares in Q2 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in AngioDynamics in Q1 2016 and held it in 21 quarters.
  • TCI Wealth Advisors's AngioDynamics position peaked at $9K in Q4 2021.
  • 134 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.